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Abstract: Endometriosis has a multifactorial etiology. The onset and progression of the disease 
are believed to be related to different pathogenic mechanisms. Among them, the environment and 
lifestyle may play significant roles. Diet, dietary supplements, physical exercise, osteopathy, 
massage, acupuncture, transcutaneous electrical nerve stimulation, and Chinese herbal medicine 
may represent a complementary and feasible approach in the treatment of symptoms related to 
the disease. In this narrative review, we aimed to examine the most updated evidence on these 
alternative approaches implicated in the self-management of the disease. In addition, several 
studies have demonstrated that endometriosis may negatively impact mental health and quality 
of life, suggesting that affected women may have an increased risk of developing psychological 
suffering as well as sexual problems due to the presence of pain. In light of these findings, we 
discuss the importance of integrating psychological interventions (including psychotherapy) 
and sexual therapy in endometriosis treatment.
Keywords: sexual therapy, diet, physical activity, alternative medicine, psychotherapy
Introduction
Endometriosis is a hormone-dependent, chronic inflammatory condition associated 
with pelvic pain symptoms and infertility.1–3 About 5% of women of reproductive age 
suffer from the disease.4 The etiology of this condition has been only partly clarified; 
numerous pathogenic factors, like lifestyle and environmental ones, have been claimed 
to be involved in the onset, maintenance, and progression of the disease.5
Although hormonal therapies represent the cornerstone in the management of 
endometriosis,1,4 the possible adjuvant role of other remedies and behaviors, such as 
diet, dietary supplements, physical exercise, osteopathy, acupuncture, and Chinese 
herbal medicine (CHM), could represent a complementary and feasible approach 
in the treatment of symptoms related to the disease. Complementary and alternative 
medicine (CAM) has been used extensively in most Asian countries since the nineteenth 
century; however, their utilization in Western countries has been rapidly growing.6 
In this narrative review, we examine the most updated evidence on these alternative 
factors implicated in the self-management of the disease.
Moreover, several studies have demonstrated that endometriosis, especially when 
symptomatic, may negatively impact mental health and quality of life (QoL),7 sug-
gesting that affected women may have an increased risk of developing psychological 
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suffering as well as sexual problems due to the presence of 
pain. In light of these evidences, we discuss the importance 
of integrating psychological interventions (including psycho-
therapy) and sexual therapy in endometriosis treatment.
In this review, the best-quality evidence was selected, 
with preference given to the most recent and definitive 
original articles and reviews. Information was identified by 
searches of Medline and references from relevant articles, 
using combinations of the Medical Subject Heading terms 
“endometriosis”, “diet”, “food”, “physical activity”, “physical 
exercise”, “alternative medicine”, “complementary alterna-
tive medicine”, “acupuncture”, “osteopathic manipulative 
therapy”, “herbal medicine”, “vitamin”, “n-acetylcysteine”, 
“resveratrol”, “endocrine disruptors”, “psychotherapy”, “deep 
dyspareunia”, “sexual therapy”, and “sexual dysfunctions”. 
The search was limited to articles in the English language. 
For most issues, papers published between December 1990 
and January 2017 were considered.
Diet
In recent years, the role of diet in the pathogenesis of endo-
metriosis has gained momentum, due to the influence of diet 
in several processes related to the disease, such as inflam-
mation, prostaglandin metabolism, and estrogen activity.8,9 
Moreover, in the last two decades, organochlorines, including 
polychlorobiphenyls and pesticides/insecticides, that can 
be ingested through various nutrients have been proposed 
as risk factors for the disease.10 In addition, the shift to a 
Western-style dietary pattern, characterized by a large intake 
of refined, processed, and canned foods, plenty of colorants, 
pesticides, preservatives, and stabilizers in theory may have 
generated an imbalance in the body, favoring a proinflam-
matory state and increasing circulating free radicals and 
oxidative stress.11 Despite these premises, the role of diet 
on endometriosis risk remains elusive, eg, in a systematic 
review of the literature by Parazzini et al8 of eleven studies, 
the results were characterized by extreme variability, and 
strong or definitive information could not be provided.
Several studies have focused on the relationship between 
endometriosis and fish oils/polyunsaturated fatty acids 
(PUFAs), because these nutrients have an anti-inflammatory 
profile and are able to reduce proinflammatory prostaglandin 
production. ω3 PUFAs can be found mostly in salmon, tuna, 
and halibut. A large study by Missmer et al9 on a popula-
tion of 70,709 US women, 1,081 of whom with a diagnosis 
of endometriosis, revealed that high intake of long-chain 
ω3 fatty acids (FAs) and decreased consumption of trans 
unsaturated FAs reduced the risk of endometriosis. Instead, 
an increased risk was associated with animal-fat ingestion, 
particularly palmitic acid.9 The ω3 FA:ω6 FA ratio has been 
investigated in three studies. Missmer et al9 and Netsu et al12 
demonstrated that a higher ratio reduced the risk of the dis-
ease; on the contrary, Khanaki et al13 found a positive correla-
tion between the ratio and the severity of the disease. Savaris 
and do Amaral14 reported a lower consumption of PUFAs in 
women affected by the disease, resulting in an imbalanced 
formation of long-chain ω3 PUFAs. In an endometriosis rat 
model, Netsu et al12 found a significant reduction in the thick-
ening of the active site for inflammation in endometriosis in 
rats fed with a diet supplemented with ω3 eicosapentaenoic 
acid. On the other hand, three other studies,15–17 did not reveal 
a significant association between intake of fish or other 
dietary fats and risk of endometriosis.
The relationship between red meat and risk of endometrio-
sis has been analyzed in three studies. An Italian case-control 
study17 found a significantly higher risk of the disease in 
women reporting higher meat and ham intake. A plausible 
explanation of the role of red meat in the pathogenesis of 
the disease could be represented by the high amount of fat 
contained in this nutrient, in particular ω6 FAs, implicated in 
the production of proinflammatory prostaglandins. However, 
this association was not replicated in other studies by Trabert 
et al16 or Heilier et al.15
Two studies have investigated the relation between 
fruit and vegetable consumption and endometriosis risk.16,17 
Parazzini et al17 found that intake of both these nutrients 
led to decreased risk; on the contrary, in the case-control 
study conducted by Trabert et al16 an increased number of 
servings/day of fruit was associated with an augmented risk 
of the disease, but no association appeared with vegetables. 
These results could be explained by the fact that nowadays 
the cultivation of fruit involves extensive use of pesticides 
and dioxins, both implicated in the production of reactive 
oxygen species, as well as in the reduction of the antioxidant 
properties of these categories of food.
In order to evaluate the potential association between cof-
fee/caffeine intake, Chiaffarino et al18 recently conducted a 
meta-analysis. Eight studies were included, six case-control and 
two cohort studies, with 1,047 endometriosis patients in total. 
The meta-analysis provided no evidence for an association 
between coffee/caffeine ingestion and risk of the disease. The 
consumption of caffeine has been extensively analyzed, due to 
its property to act on hepatic production of sex hormone binding 
globulin (SHBG), reducing testosterone bioavailability,19,20 as 
well as for its role in inhibiting aromatase, an enzyme involved 
in the conversion of androgens to estrogens.21
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The role of a gluten-free diet in the management of 
symptomatic endometriosis has also been evaluated in two 
Italian retrospective studies.22,23 The rationale of these studies 
was the potential proinflammatory role of gluten that could 
enhance the production of specific cytokines involved in the 
exacerbation of the disease. Both studies demonstrated an 
improvement in pain symptoms in women who followed a 
gluten-free diet. The possible role of gluten in the worsening 
of the disease is indeed intriguing; however, due to the scanty 
available evidence on this topic, further research is needed 
in order to confirm this hypothesis.
Physical activity
Physical activity has been identified as a possible modi-
fiable, protective factor for endometriosis. In fact, the 
protective effects of regular physical activity have been 
previously demonstrated in the treatment of other disorders 
involving inflammatory processes, such as type 2 diabe-
tes mellitus, inflammatory bowel disease, and colon and 
breast cancer.24–26
With regard to endometriosis, various etiopathogenic 
assumptions may contribute to explain why physical activity 
may be a protective factor. First, exercise may reduce 
estrogen levels and frequency of ovulation when performed 
at high levels of intensity;27 second, physical activity may 
increase SHBG levels, which would decrease bioavailable 
estrogens.28–30 Moreover, regular physical activity also reduces 
insulin resistance and hyperinsulinemia,28 which has been 
hypothesized to be associated with endometriosis. In addi-
tion, regular exercise leads to an increase in the systemic 
levels of cytokines with anti-inflammatory properties.29,30
Recently, Ricci et al27 performed a systematic review 
and meta-analysis of the literature to clarify the potential 
association between endometriosis and physical activity. 
The meta-analysis combined data from nine studies – six 
case-control studies and three cohort studies – involving 
3,355 cases for recent physical activity and 4,600 case for 
past physical activity. The summary odds ratio for endo-
metriosis for any recent versus no physical activity was 
0.85 (95% confidence interval [CI] 0.67–1.07). Compared 
to no recent physical activity, odds ratios for low and 
moderate/high exercise were 1 (95% CI 0.68–1.28) and 0.75 
(95% CI 0.53–1.07), respectively. The authors concluded 
that although physical activity may reduce the risk of the 
disease, the meta-analysis had not provided definitive sup-
port to this hypothesis.
The possible anti-inflammatory effect of physical activity 
has also been evaluated in a rat model. Rosa-e-Silva et al31 
divided 70 female rats with experimentally induced 
endometriosis in seven groups of ten animals each: sedentary-, 
light-, moderate-, and intense-exercise programs. Endometrio-
sis was induced before physical activity in three groups and 
after disease induction in the other three. A reduction in levels 
of oxidative stress, MMP9, and proliferating cell nuclear 
antigen (PCNA) was identified in all the groups that practiced 
physical exercise, indicating a reduction in proliferation, 
migration, and differentiation of endometriotic tissue.
Recently, the practice of yoga has gained worldwide 
spread, due to its ability to integrate the body and mind 
through a balanced mixture of contemplative techniques 
that are able to reduce stress and, at the same time, 
strengthen musculature.32 As stated by the World Health 
Organization, yoga has been classified as a mind–body 
practice33 that improves symptoms of various disorders, 
such as asthma and high blood pressure.34–36 Gonçalves et 
al32 evaluated the effects of yoga on 15 women with symp-
tomatic endometriosis. All patients attended yoga practice 
twice a week for 8 weeks, and at the end of the program all 
participants reported a beneficial effect of yoga in pelvic 
pain management. In addition, women stated that through 
the practice of yoga, they developed self-control and self-
awareness, with improved self-care and self-esteem. In 
conclusion, through the learning of specific postures and 
breathing and meditation techniques, yoga improved the 
ability of patients experiencing pain to control their symp-
toms. Further research is needed to confirm these promising 
preliminary and uncontrolled results.
Complementary and alternative 
medicine
As stated by the World Health Organization,37 CAM com-
prises a range of different health-related strategies that can 
be defined as predominantly operating outside the con-
ventional medical curriculum and profession. The list of 
CAMs includes several procedures and products that have 
been tested in the treatment of women with endometriosis, 
such as osteopathic manipulative therapy (OMT), massages, 
acupuncture, transcutaneous electrical nerve stimulation 
(TENS), CHM, vitamins, and dietary supplementations.
Symptomatic women with endometriosis represent a 
large catchment area for CAM. In fact, as reported by Fisher 
et al,38 patients affected were significantly more likely to 
consult a CAM practitioner or use CAM products compared 
to women without the disease. In this article, we review the 
main evidence on the use of different CAM in women with 
endometriosis.
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Osteopathic manipulative therapy and 
massage
Osteopathy is characterized by manipulative techniques, 
and can be defined as a drug-free manual medicine that 
adopts manipulations to treat somatic dysfunctions.39 OMT 
has been successfully used in the treatment of chronic back 
pain.40,41 The principle on which this practice is based is that 
inflammation of internal organs can provoke musculoskeletal 
symptoms and vice versa.42 Two studies have analyzed the 
impact of OMT on women with endometriosis. Darai et al43 
evaluated the role of OMT on the QoL of patients with deep 
infiltrating endometriosis and colorectal involvement. A total 
of 20 patients were recruited, of whom 15 (75%) completed 
the study protocol. A significant improvement in most items 
of the Short Form-36 (SF-36) questionnaire was observed, 
with an overall success rate of 80% (12 of 15 patients). 
A recent German study42 investigated the efficacy of OMT 
on 28 women with chronic pelvic pain, including 14 with a 
previous diagnosis of endometriosis. The treatment was com-
pleted by 22 patients, 17 of whom reported an improvement 
in pain symptoms. In the subcategory of women with endo-
metriosis, ten of 14 reported amelioration of the symptoms. 
Both these studies provide encouraging results to consider 
OMT a valuable additional treatment in the management of 
women with endometriosis. However, poor research design, 
paucity of data, small samples sizes, and limited study periods 
represent major sources of bias.
With regard to the potentially adjuvant role of body-
massage therapy in the treatment of endometriosis, one 
Iranian study44 enrolled 23 patients with dysmenorrhea 
and a surgically confirmed diagnosis of endometriosis. 
A statistically significant improvement in pain intensity was 
described immediately after the beginning of the massages, 
as well as at 6-week follow-up. Further studies are needed 
to determine the real role of OMT and massage therapy as 
part of a multimodal approach to the treatment of symp-
tomatic endometriosis.
Acupuncture and TeNS
Acupuncture is a therapeutic technique characterized by 
the insertion of fine metallic needles into or through the 
skin at specific sites.45 This practice has been shown to 
have the potential to interfere with pain pathways with 
different mechanisms. First, acupuncture could induce 
the release of endogenous opioids in brain-stem, subcor-
tical, and limbic structures. Second, in a mouse model, 
electroacupuncture stimulated pituitary production of 
cortisol and adrenocorticotropic hormone, facilitating an 
anti-inflammatory systemic effect.45 In addition, human stud-
ies have shown beneficial effects of prolonged acupuncture 
treatment in the deactivation of brain areas linked to the trans-
mission of pain sensations.45,46 Finally, acupuncture induces 
local effects, such as mechanical stimulation of connective 
tissue, release of adenosine at the needle-insertion site, and 
intensification of local blood flow.45
Due to its pain-alleviating effects, acupuncture is widely 
used in the treatment of different conditions.46,47 Moreover, 
major adverse effects are rarely reported.45 However, despite 
the encouraging premises, a recent Cochrane meta-analysis48 
that evaluated the effectiveness and safety of acupuncture 
and acupressure in the treatment of primary dysmenorrhea 
when compared with placebo, no treatment, or conventional 
medical treatment showed that the quality of the available 
evidence was low or very low for all comparisons and insuf-
ficient to demonstrate the effectiveness of this technique.
Lund and Lundeberg46 performed a meta-analysis to 
summarize the clinical effects of acupuncture on pelvic 
pain related to endometriosis. Three studies were included, 
with a total of 121 women with diagnosed endometriosis 
enrolled. One of the studies49 was a retrospective case 
series based on the history of two adolescent endometriosis 
patients treated with acupuncture. Also in Wayne et al,50 
only adolescent women with endometriosis were enrolled. 
In this study, the authors performed a particular Japanese-
style acupuncture technique that differed from the traditional 
Chinese technique for the use of smaller needles and shal-
lower insertion sites, making this method less invasive and 
better received by an adolescent population. In all studies, 
acupuncture had beneficial effects on pain intensity. In addi-
tion, patients reported an increase in social activities and 
school attendance in one study49 and an improvement in 
health-related QoL in the other two studies.50,51 None of 
the studies reported side effects. The overall results of the 
effects of acupuncture on pelvic pain related to endometriosis 
seem encouraging, particularly among adolescent women. 
However, no definitive conclusions can be drawn from these 
studies, due to the small sample sizes.
TENS is a non-invasive and low-cost technique based 
on the use of mild electrical impulses applied to the intact 
surface of the skin with the objective of stimulating low-
threshold nerves to relieve pain and favor the release of 
endogenous opioids.52,53 Based on a review of Proctor et al54 
on dysmenorrhea in general, TENS has been mentioned 
as alternative short-term pain management in women with 
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dysmenorrhea in a consensus document on the management 
of endometriosis.55
Only one randomized controlled trial has investigated 
the role of TENS as complementary pain treatment in women 
with endometriosis. Mira et al53 evaluated the effectiveness 
of TENS on persistent pelvic pain, dyspareunia, and QoL 
in symptomatic women with deep endometriosis. They 
enrolled 22 patients and randomized them into two groups: 
acupuncture-like TENS (n=11) and self-applied TENS 
(n=11). In both groups, TENS was applied for 8 weeks at 
the S3–S4 region. For all participants, TENS provided pain 
relief, with statistically significant improvement in pelvic 
pain, deep dyspareunia, and dyschezia; for the latter type 
of pain, relief was observed only with the application of 
acupuncture-like TENS. No improvement was registered 
for dysmenorrhea or dysuria. QoL was evaluated through 
the Endometriosis Health Profile questionnaire; after treat-
ment, total scores were significantly reduced, indicating an 
amelioration of QoL. Finally, patients reported an improve-
ment in emotional well-being, social support, and self-image. 
Acupuncture and TENS could represent alternative options 
in patients with symptomatic endometriosis resistant to 
hormonal therapy. However, the evidence is still scarce, and 
further larger studies are needed to confirm these promising 
preliminary results.
Chinese herbal medicine
CHM comprises the use of herbal formulae of different herbal 
ingredients (10–20) chosen from a materia medica of several 
hundred common herbs that are prepared as boiled decoc-
tions, dried extracts, or pills.6 These compounds could be 
administered either orally, through enema, or an intramuscu-
lar route. In China, herbal medicine (HM) is widely applied, 
and is considered a routine treatment in patients with endo-
metriosis, due to its theoretical ability to reduce pain, prevent 
recurrence, and enhance fertility. At the basis of HM efficacy, 
there would be the potential anti-inflammatory activity on 
endometrial cells. Moreover, its use on animal models has 
shown its ability to suppress endometriotic implants.56,57
Flower et al58 conducted a Cochrane review to clarify the 
effectiveness and safety of CHM in relieving endometriosis-
related pain and infertility. Two Chinese randomized control 
trials were included,59,60 with a total of 158 patients enrolled. 
Both studies were of limited quality. One study compared 
the postsurgical administration of CHM (oral plus enema) 
to gestrinone, with comparable benefits on pain and preg-
nancy rates.59 In the other study, women were divided in 
three groups: oral CHM, oral plus enema CHM, or danazol. 
Oral plus enema administration resulted in greater reduc-
tion in dysmenorrhea-pain scores than danazol, whereas 
no differences were reported regarding vaginal nodule 
tenderness, lumbosacral pain, or dyschezia.60 In both studies, 
there were fewer side effects with CHM. However, as stated 
by Flower et al, “… more rigorous research is required 
to accurately assess the potential role of CHM in treating 
endometriosis”.58 In addition, the authors adopted inadequate 
comparison treatments. In fact, danazol and gestrinone are 
no longer used as conventional and first-line treatment for 
endometriosis. For these reasons, a control group of women 
using estroprogestins or progestins, which are nowadays 
considered the first-line medical treatments of endometriosis, 
would have been advisable.
Zhu et al61 conducted a prospective randomized study 
comparing laparoscopy alone with laparoscopy followed by 
treatment with oral contraceptives (OCs) or a combination 
of OCs and the Dan’e mixture, a Chinese herbal combina-
tion that has similar properties to danazol. The OC was 
administered continuously for 63 days after surgery, while 
HM was added at a dosage of 30 g/day for the latter 30 days. 
Only infertile patients with minimal/mild endometriosis were 
enrolled. A total of 156 patients were randomized into the 
three study groups. The primary outcome of the study was 
pregnancy rate and live-birth rate. Follow-up lasted 12 and 
14 months in women who had undergone laparoscopy alone 
and in those who had received medical treatment after 
surgery, respectively. Differences in pain scores were also 
evaluated. No significant differences were observed among 
the three groups regarding pregnancy rate or live-birth rate. 
Women under medical therapy (OCs alone or OCs plus HM) 
had lower pain scores compared with the laparoscopy-alone 
group; no difference in pain scores was identified between the 
two medical treatment groups. In conclusion, the addition of 
the herbal mixture did not provide any advantage in terms of 
enhancing fertility or in terms of pain reduction.
vitamins and dietary supplements
Vitamins are organic compounds and vital nutrients that 
an organism requires in limited amounts.62 In the endo-
metriosis field, one of the most studied vitamins is certainly 
vitamin D, due to its antiproliferative, anti-inflammatory, 
and immunomodulatory properties.63 Moreover, vitamin D 
receptor is expressed in ovarian tissue, endometrium, and 
fallopian epithelial cells.63 Lasco et al64 evaluated the effect 
of a single dose of 300,000 IU of cholecalciferol (vitamin D
3
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for treatment of primary dysmenorrhea, demonstrating a 
significant decrease in pain in the supplemented group. 
Moreover, a selective vitamin D-receptor agonist, elo-
calcitol, has been shown to diminish endometriosis 
development in a murine model.65 Recently, Miyashita 
et al66 performed an in vitro study to assess the effects of 
1,25-dihydroxyvitamin D
3
 (1,25[OH]
2
D
3
) on human endo-
metriotic stromal cells: 1,25(OH)
2
D
3
 significantly reduced 
the levels of inflammatory mediators, such as IL1β, IL8, 
prostaglandin activity, MMP2, and MMP9, and decreased 
endometriotic stromal cell numbers and DNA synthesis. 
On the contrary, a recent double-blind clinical trial67 on 
39 patients with surgical diagnosed endometriosis investigat-
ing the effect of vitamin D supplementation on pelvic pain 
did not find any significant difference between supplemented 
women and a placebo group. In the last two decades, vari-
ous clinical trials have evaluated the relationship between 
endometriosis and vitamin D serum levels, with contradic-
tory results (Table 1). Finally, Ciavattini et al72 assessed 
vitamin D serum levels in a cohort of 49 patients with ovarian 
endometrioma, showing deficient vitamin D levels in about 
85% of the study population. In addition, a significant linear 
correlation between 25-hydroxyvitamin D (25(OH)D) serum 
levels and the diameter of the cyst emerged.
Other compounds that could play a role in the pathogenesis 
of endometriosis are vitamin A, vitamin C, and β-carotene, 
due to their antioxidant activity. In fact, oxidative stress may 
exert a central role in the development and progression of 
the disease through an intensification of growth and adhesion 
of endometrial cells in the peritoneal cavity.57 Mier-Cabrera 
et al73 discovered low concentrations of vitamin C in the 
peritoneal fluid of women with endometriosis, and dem-
onstrated an imbalance between antioxidant and oxidant 
markers in favor of the latter. However, a 6-month specific 
antioxidant diet enriched with vitamins (A, B
6
, C, E), lactic 
ferments, mineral salts, and ω3 and ω6 FAs had no impact 
on the recurrence rate of endometrioma when compared with 
laparoscopy plus placebo.74
N-acetylcysteine (NAC) is a nutritional supplement that 
acts as a direct precursor to glutathione synthesis, and has been 
successfully used for a wide range of metabolic disorders, 
pulmonary diseases, hepatotoxicity, and immunotoxicity.75 
NAC could reduce the release of inflammatory cytokines and 
is able to interfere the inflammation cascade process con-
trolled by NFκB activity.75 NAC acts through the activation 
of numerous molecular mechanisms, all converging into a 
proliferation-to-differentiation switch that brings a reduction 
in cell proliferation and downregulation of the inflammatory 
cascade.76 Food sources of NAC include garlic, broccoli, red 
pepper, onion, and animal protein, in particular such meats as 
pork, chicken, turkey, and duck.77 In an Italian case-control 
study,76 women supplemented with NAC (600 mg three 
times a day for 3 days a week for 3 months versus placebo) 
showed a reduction in mean endometrioma diameter and an 
improvement in dysmenorrhea, dyspareunia, and chronic 
pelvic pain, without reporting any adverse reactions. Pittaluga 
et al78 explored NAC action in vivo by using a mouse model 
of endometriosis, demonstrating a significant reduction in 
endometrioma weight in the treated group compared with 
the control group.
Resveratrol (trans-3.4′,5-trihydroxystilbene) is a phy-
toalexin polyphenol produced by some grape species, ber-
ries, and nuts in response to ultraviolet radiation or fungal 
infections.79 Significant concentration of this compound 
could be find in red wine, thanks to the high concentration 
of resveratrol in the skin of grapes. Several studies have 
demonstrated the antiangiogenic, anti-inflammatory, and 
antioxidant properties of resveratrol, which has been found to 
be beneficial for multiple diseases, such as cancer and cardio-
vascular diseases.80,81 In the first study evaluating the effects 
of resveratrol on endometriosis lesions,82 daily oral gavage of 
resveratrol significantly diminished the number and size of 
Table 1 Relationship between endometriosis and 25(OH)D serum levels (literature data 1990–2016)
Study Country Number of patients enrolled 25(OH)D serum levels
Hartwell et al68 Denmark 42 Normal
Somigliana et al69 Italy 140 (endometriosis, n=87; controls, n=53) Increased
Agic et al70 Germany 79 (endometriosis, n=46; controls, n=33) Normal
Harris et al71 US 70.556 (endometriosis, n=1,385; controls n=69,171) Decreased
Miyashita et al66 Japan 76 (endometriosis n=39;a controls n=37) Decreasedb
Ciavattini et al72 Italy 49c Decreased
Notes: aMild endometriosis (n=17, stages 1 and 2), severe endometriosis (n=22; stages 3 and 4); bserum levels of 25(OH)D in samples from patients with severe endometriosis 
were significantly lower than the levels detected in samples from the controls and the patients with mild endometriosis; conly patients with singleton endometrioma 
were included.
Abbreviation: 25(OH)D, 25-hydroxyvitamin D.
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endometriotic lesions in mouse models. These preliminary 
results have been confirmed by two other studies.83,84 In both 
studies, performed on mouse models, resveratrol significantly 
reduced the number and volume of the endometriotic lesions, 
through a reduction in cell proliferation, vascular density, 
and favoring apoptosis. In addition, another experimental 
study compared the effects of resveratrol alone and in com-
bination with leuprolide acetate, a gonadotropin-releasing 
hormone analog.85 The authors found that resveratrol was 
as effective as leuprolide acetate in endometriosis manage-
ment when used alone; on the other hand, the combination of 
resveratrol and leuprolide acetate did not show any beneficial 
additive effect.
One of the major sources of resveratrol is red wine; 
however, long-term consumption of this beverage is not 
recommended, due to the alcohol content; other food products 
should be contemplated as a different source of resvera-
trol, as well as compressed pills with the necessary dose.83 
Moreover, further studies on human subjects are needed, in 
order to clarify the real effectiveness of this polyphenol and 
the needed dosage to achieve inhibition of endometriotic 
cell growth.
Endocrine disruptors
Endocrine-disrupting chemicals (EDCs) include any exog-
enous chemical or mixture of chemical substances that can 
interfere with any aspect of hormonal action.86 With regard to 
endometriosis, experimental research and studies on primates 
have posed questions on a possible role of these chemicals 
in the pathogenesis of the disease.87 EDCs could be involved 
in the pathogenesis of endometriosis due to their ability in 
altering hormone synthesis, modulating receptors, or acting 
as agonists or antagonists.87
In particular, dioxin and dioxin-like compounds rep-
resent one of the most studied substances.88 These lipo-
philic substances are ubiquitous environment pollutants 
that mainly enter into the human body through food and 
accumulate in tissue with high-fat content.89 In a study on 
rhesus monkeys, a dose-dependent relation was observed 
between 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 
dioxin-like polychlorinated biphenyls (PCBs) and peritoneal 
endometriosis.90,91 It has been hypothesized that TCDD may 
provoke the proliferation of endometrial cells that are sig-
nificant for endometrial angiogenesis.92 These results were 
not confirmed in a large epidemiological study,93 which 
did not demonstrate any increased incidence of the disease 
in women living in Seveso, Italy, where in 1976 there 
was a factory explosion. The authors reported a doubled, 
nonsignificant risk for endometriosis among women with 
serum TCDD levels of 100 parts per trillion or higher, but 
no clear dose response. On the contrary, Heilier et al94 dem-
onstrated increased serum levels of dioxin-like compounds 
in women with endometriosis, in particular in those with 
deep endometriotic nodules. The potential implication of 
environmental organochlorinated persistent pollutants, espe-
cially dioxins and PCBs, on endometriosis has been evaluated 
in an Italian case-control study.95 The authors showed an 
association between increased PCBs and 1,1-dichloro-2,2-
bis(4-chlorophenyl)ethene (p,p’-DDE) serum levels and the 
risk of endometriosis.
Another extensively studied compound is bisphenol 
(BP) A, a substance widely used in the manufacture of 
plastics. BPA has estrogenic properties and can bind 
in vitro and in vivo to α- and to a lesser degree β-estrogen 
receptors;96 consequently, BPA could be involved in 
the occurrence of estrogen-dependent diseases, such as 
endometriosis.97 In addition, a possible adverse effect 
of BPA on fertility has been suggested.98,99 In particular, 
Caserta et al99 demonstrated that women with high con-
centrations of BPA were significantly more frequently 
infertile than those with normal BPA levels. Cobellis 
et al100 measured the levels of BPA and BPB in the blood 
serum of 58 women with endometriosis and eleven healthy 
controls. The two BPs were not detected in any of the con-
trol sera, whereas it was measured in 63.8% of the samples 
derived from endometriotic patients. On the contrary, two 
studies evaluating urinary BPA concentrations did not 
observe any association with the disease.101,102 Finally, 
Signorile et al103 demonstrated in a mouse model that 
offspring of animals exposed to BPA during pregnancy 
developed endometriosis-like structures significantly more 
frequently than controls. More data are needed, in order 
to disentangle these conflicting results and assess the 
relationship between EDCs and endometriosis.
Psychological interventions
A growing number of quantitative and qualitative studies 
have shown that endometriosis may have a negative impact 
on women’s psychological health and health-related QoL. 
Some of these works focused on endometriosis itself as a 
gynecological chronic disease often associated with anxiety 
and depression due to prognostic uncertainty and threat of 
infertility (as well as ascertained infertility).104,105 Other 
studies focused on endometriosis-related pelvic pain, empha-
sizing how having versus not having pelvic pain (especially 
chronic pelvic pain) may lead to different psychological 
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outcomes.7 Despite the increasing amount of evidence, 
research examining the efficacy of psychological interven-
tions (including psychotherapy) with endometriosis patients 
is still scarce.
In a recent study, Meissner et al106 investigated whether 
psychotherapy with somatosensory stimulation (ie, different 
acupuncture-point stimulation techniques) could lead to 
improved QoL and pelvic pain in 67 endometriosis patients 
randomly assigned to the intervention (n=35) or to a wait-
ing list (n=32). Not only did this type of intervention lead to 
significant improvement in global pain, physical and mental 
QoL at 3-month follow-up but also these positive changes 
remained stable at 6 and 24 months after the intervention, 
when all participants (including those assigned to the waiting 
list) had been treated.
Hansen et al107 reported long-term effects (6-year 
follow-up) of a ten-session mindfulness-based psychological 
intervention (both individual and group sessions). The overall 
intervention involved ten women with endometriosis-related 
chronic pelvic pain, and comprised mindfulness training, 
visualization techniques, counseling, group support, and 
patient education with a specific focus on fatigue, quality 
of sleep, job, relationships, and family issues. Women 
showed a global long-lasting improvement on health-related 
QoL, with no decline when findings were compared with 
those derived from a first assessment at 12 months after 
the intervention.108
Overall, the extant endometriosis literature reports 
short- and long-term outcomes of psychological interven-
tions focused mainly on endometriosis-related symptoms 
and especially on pelvic pain, which indeed represents a 
major clinical problem in women with the disease. There is 
evidence that chronic pelvic pain negatively affects mental 
health, but recent qualitative research109 has shown that 
endometriosis might have a negative pervasive impact on 
women’s psychological health for reasons other than pelvic 
pain. For instance, the disruption caused by the disease and 
the inability to restore a sense of biographical continuity 
is an important source of anxiety and depression.110 This 
growing body of knowledge, which also suggests the extent 
to which women’s sense of female identity can be negatively 
affected by endometriosis, indicates that psychological 
interventions with distressed endometriosis patients should 
not be exclusively focused on pain symptoms; a proper 
psychotherapeutic intervention aimed at helping women 
integrate endometriosis into their own history should be 
encouraged. However, there is no research systematically 
exploring the effectiveness of psychotherapy (either cogni-
tive behavioral or psychodynamic therapy) in women with 
endometriosis. Overall, based on our clinical practice and 
previous research,7,110,111 we suggest that women may benefit 
from supportive–expressive psychotherapeutic interven-
tions (either individual or group interventions) aimed at 
facilitating the expression of deepest thoughts and feelings 
about endometriosis, as well as at empowering their female 
identity. Adequately designed trials are needed to define the 
magnitude of the benefit of psychotherapeutic interventions 
in different clinical conditions.
Sexological interventions
A consistent percentage of women with endometriosis 
(about 60%–70%) suffer from some form of sexual dys-
function.112 In particular, endometriosis is associated with 
an increased risk of deep dyspareunia, with potentially 
negative effects on global female sexual functioning, inti-
mate and couple relationships, psychological well-being, 
and QoL.112
Typically, deep dyspareunia is related to deep infiltrating 
endometriosis, characterized by the presence of endometri-
otic lesions infiltrating the posterior vaginal fornix, the 
pouch of Douglas, the uterosacral ligaments, the bladder, 
or the rectum. In these cases, it is plausible that pain during 
intercourse is predominantly elicited by mechanical pressure 
on lesions occurring during coitus, or by traction of inelastic 
and scarred endometriotic tissue.113,114 In patients with other 
forms of endometriosis, pain during intercourse can also 
be triggered by a condition of severe pelvic inflammation. 
Moreover, women with endometriosis under hormonal 
therapy may also experience dyspareunia due to vaginal 
dryness caused by the treatment itself.
However, dyspareunia is not the only sexual complaint in 
women suffering from endometriosis. Several studies have 
shown that pain during intercourse is commonly associated 
with a broad range of different sexual dysfunctions, such as 
hypoactive sexual desire, lubrication, arousal, and orgasm 
disorders. All these sexual dysfunctions frequently coexist, 
and may result in poor global female sexual satisfaction and 
couple disagreement.115–117 The vicious circle of perpetration 
of sexual dysfunction in women with endometriosis com-
monly starts with the presence of recurrent dyspareunia, and 
the consequent fear and anticipation of pain at every attempt 
at sexual intimacy. Sexual response is a multifaceted and 
complex phenomenon, which requires physiological and 
mental activation to erotic stimuli. Fear and anticipation of 
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pain represent two of the most powerful inhibitors of the 
sexual response cycle, and the main sources responsible for 
low desire and lubrication.118–120
Based on these premises, reducing pain at intercourse 
represents the first step in the treatment of women with 
sexual dysfunctions associated with endometriosis. This 
goal can be achieved in many cases by the use of hormonal 
treatment (particularly with long-term low-dose progestin 
therapy), by surgery, or by other alternative methods previ-
ously described (ie, TENS, NAC). However, specific alter-
native methods can be suggested to women facing painful 
intercourse, although there is no scientific consensus on this 
particular issue. For instance, the use of lubrication agents 
can help women in treating the pain associated with sexual 
activities (reducing the friction caused by penetration) as 
a consequence of low lubrication levels due to hypoactive 
sexual desire.
Dyspareunia can also be treated by modifying sexual 
technique. For example, increasing the amount of foreplay 
and delaying penetration can amplify genital lubrication 
and consequently decrease the pain associated with pene-
tration. Moreover, frequently patients indicate that specific 
sexual positions are more painful than others. Trying 
alternative sexual positions may help in reducing pain 
associated with intercourse, facilitating slow and gentle 
penetration. In addition, some women find that sexual 
intimacy is more enjoyable and satisfying at certain times 
of the month, whereas immediately before or after men-
struation sexual intercourse is more painful. Furthermore, 
besides pain due to pelvic inflammation or anatomical dis-
tortion related to endometriosis, psychological dimensions 
(such as anxiety, depression, and personality traits) or rela-
tional mechanisms (feelings, behaviors, relational adjust-
ment) play an important role in sexual functioning.110,120,121 
Consequently, a comprehensive approach considering 
all the various aspects of female sexuality should be 
strongly encouraged.
When sexual difficulties are particularly worrying and 
distressing, sexual therapy can be very useful, and could 
represent a rather pleasant experience for the couple. Sexual 
therapy is a particular therapeutic technique specifically 
designed to help people facing sexual difficulties, created with 
the aim of improving their physical intimacy. It is provided by 
licensed physicians, psychologists, or psychotherapists who 
have undergone specific training, and provides an outlet for 
women to disclose and discuss their sexual problems with a 
supportive specialized professional figure.
Sexual therapists can also suggest relaxation and commu-
nication techniques, which could facilitate better physical and 
emotional relationships. Additionally, women may ask sexual 
therapists about sensitive issues regarding sexual techniques 
or alternative sexual practices. Moreover, sexual therapy may 
facilitate open and honest communication between women 
and their partners. Further research is needed to confirm the 
potential beneficial effects of sexual therapy on endometriosis 
patients and their love life.
Conclusion
Numerous cofactors can play a role in the progression and 
maintenance of endometriosis, which is thus a complex 
multifactorial disease. In this review, we have analyzed the 
role of several factors (Table 2), such as diet and physical 
exercise. In both cases, scientific data are scarce and incon-
sistent. Moreover, the adjuvant effect of CAM is difficult 
to interpret, because most of the available evidence was 
derived from nonrandomized uncontrolled trials, case reports, 
or case series, which are subject to many sources of bias. 
High-quality studies are needed, in order to evaluate the 
real effectiveness of the different CAM approaches in the 
treatment of symptomatic endometriosis.
Hormonal therapy represents the treatment of choice in 
patients with endometriosis; with this in mind, we could con-
sider CAM a supplementary option to be added to hormonal 
treatment, or as a valuable opportunity for those women in 
whom medical therapy is contraindicated. In particular, some 
interventions, such as the introduction of a gluten-free diet 
and regular physical exercise, may have a beneficial impact 
on symptoms related to the disease. On the other hand, other 
practices, including CHM, NAC, and resveratrol, have been 
proposed as alternative treatments for endometriosis. Encour-
aging results have been found on mouse models with dietary 
supplements, such as resveratrol and NAC. However, further 
studies are needed on human subjects, in order to evaluate 
their role in the treatment of the disease.
Finally, the importance of a multidisciplinary team, 
including an expert sexual therapist and a psychologist, 
appears crucial in order to deal adequately with all the 
multifaceted repercussions that women with endometriosis 
often experience, but may be reluctant to describe and 
address. In this regard, the approach to every woman with 
endometriosis should be individualized, proposing the best 
treatment options based on the different symptoms and 
problems distressing the patient, and taking into account her 
preferences and priorities.
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